Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment
Exploration · 2024-10 · 4 (5)
DOI: 10.1002/exp.20230142 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Exploration, online erschienen am 05.03.2024. Verfasst von Jiaoying Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou China. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a recurring chronic inflammatory disease. Current treatment strategies are aimed at alleviating clinical symptoms and are associated with gastrointestinal or systemic adverse effects. New delivery strategies are needed for the treatment of IBD. Bacteria are promising biocarriers, which can produce drugs in situ and sense the gut in real time. Herein, we focus on recent studies of engineered bacteria used for IBD treatment and introduce the application of engineered bacteria in the diagnosis. On this basis, the current dilemmas and future developments of bacterial delivery systems are discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou China.
- National Key Laboratory of Advanced Drug Delivery and Release Systems College of Pharmaceutical Sciences Zhejiang University Hangzhou China.
- Department of Bioengineering University of California Los Angeles California USA.
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang China.
- Liangzhu Laboratory Zhejiang University Hangzhou China.
ORCID-Profile: Hongjun Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lu, J., Shen, X., Li, H., & Du, J. (2024). Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment. Exploration, 4(5). https://doi.org/10.1002/exp.20230142
Vancouver
Lu J, Shen X, Li H, Du J. Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment. Exploration. 2024;4(5). doi:10.1002/exp.20230142
BibTeX
@article{Lu2024,
author = {Lu, Jiaoying and Shen, Xinyuan and Li, Hongjun and Du, Juan},
title = {Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment},
journal = {Exploration},
year = {2024},
volume = {4},
number = {5},
doi = {10.1002/exp.20230142}
}
EUVIMED